<article id="chirivella_2009_p" class="slide" data-ag-slide-name="Chirivella 2009 (P)">
    <div class="basic">
      <h1 data-ag-editable="Chirivella 2009 (P) Main Title">Suboptimal chemotherapy delivery reduces overall survival in curative settings<sup>1</sup></h1>
      <div id="rdi_page1_data_holder_p">
         <ul class="red_dot_list" data-ag-editable="Chirivella 2009 (P) List Items">
            <li id="li1"> An analysis of 793 patients with breast cancer showed that more than 75% with an RDI ≥85% survived for 10 years after chemotherapy<sup>1</sup></li>
            <li id="li2"> Being unable to deliver the planned dose intensity of adjuvant chemotherapy can compromise survival outcomes<sup>1,2</sup></li>
            <li id="li3">Overall survival is significantly improved in NHL patients treated with R-CHOP-21 therapy and achieving RDI ≥90%<sup>2</sup></li>
         </ul>
      </div>
      <div id="chirivella_2009_p_graph_holder">
         <div id="chirivella_2009_p_large" class="main_content_style">
            <img src="content/images/pragmatist_pages/rdi/page1_graph_large.png" width="807" height="495" data-ag-editable="Chirivella 2009 (P) Graph Background" />
            <div id="chirivella_2009_p_graph_content_large">
                <h3 id="graph1_title_large" data-ag-editable="Chirivella 2009 P Graph Title">Overall survival rates for breast cancer patients based on relative<br/> dose intensity (RDI) of chemotherapy</h3>
                <p id="graph1_vertical_axis_title_large" data-ag-editable="Chirivella 2009 P Vertical Axis Title">Survival probability</p>
                <ul id="graph1_vertical_axis_value_large" data-ag-editable="Chirivella 2009 P Graph Vertical Axis Values">
                    <li>1,0</li>
                    <li>0,8</li>
                    <li>0,6</li>
                    <li>0,4</li>
                    <li>0</li>
                </ul>
                <ul id="graph1_horizontal_axis_value_large" data-ag-editable="Chirivella 2009 P Graph Vertical Axis Values">
                   <li>0</li>
                   <li>2</li>
                   <li>4</li>
                   <li>6</li>
                   <li>8</li>
                   <li>10</li>
                </ul>
                <p id="graph1_horizontal_axis_title_large" data-ag-editable="Chirivella 2009 P Horizontal Axis Title Large">Overall survival (years)</p>
                <p id="graph1_text_1_large" data-ag-editable="Chirivella 2009 P Graph Text 1 Large">RDI ≥85%</p>
                <p id="graph1_text_2_large" data-ag-editable="Chirivella 2009 P Graph Text 2 Large">RDI &lt;85%</p>
                <p id="graph1_text_3_large" data-ag-editable="Chirivella 2009 P Graph Text 2 Large">P=0.0055</p>
                <p id="graph1_bottom_text_large" data-ag-editable="Chirivella P 2009 Bottom Text Large">Adapted from Chirivella L <span class="et_al">et al.</span> Breast Cancer Res Treat 2009; 114(3);479-484</p>
            </div>
         </div>
      </div>
    </div>
    <!-- Reference Information Starts -->
    <div class="enlarge_graph" id="enlarge_graph_chirivella_2009_p"></div>
    <div class="lightbox_data" id="chirivella_2009_p_refs">
       <div class="main_content_style">
          <p><strong data-ag-editable="Chirivella 2009 (P) References Title">References:</strong></p>
          <div data-ag-editable="Chirivella 2009 (P) References List">
             <ol>
                <li>Chirivella L <em>et al</em>. Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Res Treat 2009; 114(3):479-484</li>
                <li>Pettengell R <em>et al</em>. Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy. Ann Hematol 2008; 87(5):429-430</li>
             </ol>
          </div>
       </div>
    </div>
    <!-- Reference Information Ends -->
</article>